This inventor holds 4 USPTO granted patents. Top assignees: Iqvia Inc., Quintiles Transnational Corporation. Active years: 2015-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2024
Title: **The Innovations of Daniel D Siders: Pioneering Predictive Clinical Planning**
Introduction
Daniel D Siders is a notable inventor based in Westfield, Indiana, recognized for his contributions to the field of clinical planning and design. With a total of four patents to his name, Siders has been instrumental in advancing methodologies that enhance the efficiency and effectiveness of clinical trials.
Latest Patents
Among his latest innovations is a patent that details methods and systems for predictive clinical planning and design. This method includes instantiating multiple data objects that encompass clinical trial information. It features a graphical user interface displayed on various screens, allowing users to visualize critical aspects of clinical trials through a network of graphical nodes. The innovative process involves receiving selections and modifications from users, and effectively propagating updates to ensure that critical data is accurately represented within the system.
Career Highlights
Throughout his career, Siders has worked with leading organizations such as Quintiles Transnational Corporation and IQVIA Inc. His roles in these companies have allowed him to collaborate with various professionals and contribute to significant advancements in clinical trial methodologies.
Collaborations
Siders has worked alongside notable colleagues, including Donald R Harder and Leslie Thomas. These collaborations underscore the collaborative nature of innovation within the clinical research community, highlighting how teamwork can lead to impactful technological advancements.
Conclusion
Daniel D Siders stands out as an innovator in the clinical planning domain. His patented methods and systems have the potential to revolutionize how clinical trials are executed, ensuring that they are more efficient and data-driven. With a track record of collaboration and a commitment to innovation, Siders continues to pave the way for future advancements in clinical research and design.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
